Understanding breast cancer as a global health concern

Louise Wilkinson, Toral Gathani, Louise Wilkinson, Toral Gathani

Abstract

Breast cancer is now the most commonly diagnosed cancer in the world. The most recent global cancer burden figures estimate that there were 2.26 million incident breast cancer cases in 2020 and the disease is the leading cause of cancer mortality in women worldwide. The incidence is strongly correlated with human development, with a large rise in cases anticipated in regions of the world that are currently undergoing economic transformation. Survival, however, is far less favourable in less developed regions. There are a multitude of factors behind disparities in the global survival rates, including delays in diagnosis and lack of access to effective treatment. The World Health Organization's new Global Breast Cancer Initiative was launched this year to address this urgent global health challenge. It aims to improve survival across the world through three pillars: health promotion, timely diagnosis, and comprehensive treatment and supportive care. In this article, we discuss the key challenges of breast cancer care and control in a global context.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: 10.3322/caac.21660
    1. United Nations Development Programme . Human development report. 2020. Available from:
    1. Cancer Research UK. Breast Cancer Statistics. 2021. Available from: [Accessed Aug 2021].
    1. Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health 2020; 8: e1027–37. doi: 10.1016/S2214-109X(20)30215-1
    1. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360: 187–95. doi: 10.1016/S0140-6736(02)09454-0
    1. Collaborative Group on Hormonal Factors in Breast Cancer . Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13: 1141–51. doi: 10.1016/S1470-2045(12)70425-4
    1. Key T, Appleby P, Barnes I, Reeves G. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606–16. doi: 10.1093/jnci/94.8.606
    1. Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, et al. . Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol 2021; 22: 1071–80. doi: 10.1016/S1470-2045(21)00279-5
    1. Collaborative Group on Hormonal Factors in Breast Cancer . Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358: 1389–99. doi: 10.1016/S0140-6736(01)06524-2
    1. Gathani T, Ali R, Balkwill A, Green J, Reeves G, Beral V. Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study. Br J Cancer 2013; 7: 224–9. doi: 10.1038/bjc.2013.632
    1. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790–801. doi: 10.1016/S1470-2045(12)70211-5
    1. Beral V, Peto R. UK cancer survival statistics. BMJ 2010; 341: c4112. doi: 10.1136/bmj.c4112
    1. Brand NR, Qu LG, Chao A, Ilbawi AM. Delays and barriers to cancer care in low- and middle-income countries: a systematic review. Oncologist 2019; 24: e1371–80. doi: 10.1634/theoncologist.2019-0057
    1. Denny L, de Sanjose S, Mutebi M, Anderson BO, Kim J, Jeronimo J, et al. . Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet 2017; 389: 861–70. doi: 10.1016/S0140-6736(16)31795-0
    1. World Health Organisation . New global breast cancer intiative highlights renewed commitment to improve survival. 2021. Available from:
    1. World Health Organisation . WHO guide to the early diagnosis of cancer. 2017. Available from:
    1. World Health Organisation . Universal Health Coverage (UHC). 2021. Available from:
    1. Sirohi B, Chalkidou K, Pramesh CS, Anderson BO, Loeher P, El Dewachi O, et al. . Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. Lancet Oncol 2018; 19: e395–406. doi: 10.1016/S1470-2045(18)30342-5
    1. Ginsburg O, Yip C-H, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, et al. . Breast cancer early detection: a phased approach to implementation. Cancer 2020; 126(Suppl 10): 2379–93. doi: 10.1002/cncr.32887
    1. Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health 2019; 15: 3. doi: 10.1186/s12992-018-0446-6

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren